Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes

Drug Metabolism and Disposition

Volumn 37, Issue 11, 2009, Pages 2228-2235

  Le Vee, Marc ^a   Lecureur, Valérie ^a   Moreau, Amélie ^a   Stieger, Bruno ^b   Fardel, Olivier ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CYTOCHROME P450; GLYCOPROTEIN P; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTING POLYPEPTIDE; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; PHENOBARBITAL; SCATTER FACTOR; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG TRANSPORT; EFFUSION; GENE TARGETING; HEPATITIS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELLS, CULTURED; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; MEMBRANE TRANSPORT PROTEINS; RECOMBINANT PROTEINS;

EID: 70350326029     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.028035     Document Type: Article

References (39)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715. (Pubitemid 23317282)
2. Barreiros AP, Sprinzl M, Rosset S, Höhler T, Otto G, Theobald M, Galle PR, Strand D, and Strand S (2009) EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytes. Int J Cancer 124:120-129.
3. Borst P, Zelcer N, and van de Wetering K (2006) MRP2 and 3 in health and disease. Cancer Lett 234:51-61.
4. Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W, Wan YJ, Moore DD, and Klaassen CD (2003) Induction of multidrug resistance protein 3 (Mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos 31:1315-1319. (Pubitemid 37310319)
5. Chouteau P, Le Seyec J, Cannie I, Nassal M, Guguen-Guillouzo C, and Gripon P (2001) A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol 75:11565-11572. (Pubitemid 33063248)
6. De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, and Crestani M (2001) The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276:30708-30716. (Pubitemid 37384926)
7. Donato MT, Gómez-Lechón MJ, Jover R, Nakamura T, and Castell JV (1998) Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. J Pharmacol Exp Ther 284:760-767. (Pubitemid 28086669)
8. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, and Groothuis GM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008-G1016. (Pubitemid 39423693)
9. Funk C (2008) The role of hepatic transporters in drug elimination. Expert Opin Drug Metab Toxicol 4:363-379.
10. Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, et al. (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831-G841. (Pubitemid 41532576)
11. Gerloff T, Geier A, Stieger B, Hagenbuch B, Meier PJ, Matern S, and Gartung C (1999) Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology 117:1408-1415.
12. Gómez-Lechón MJ, Donato MT, Castell JV, and Jover R (2004) Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5:443-462.
13. Habib SL, Srikanth NS, Scappaticci FA, Faletto MB, Maccubbin A, Farber E, Ghoshal AK, and Gurtoo HL (1994) Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy. Toxicol Appl Pharmacol 124:139-148. (Pubitemid 24079044)
14. Iwakiri T, Okumura M, Matsunaga N, Ichihara E, Shiotsuki S, Nagata M, Kumagai Y, Kai H, and Arimori K (2008) Hepatocyte growth factor increases uptake of estradiol 17β-D-glucuronide and Oatp1 protein level in rat hepatocytes. Eur J Pharmacol 580:19-26.
15. Jigorel E, Le Vee M, Boursier-Neyret C, Bertrand M, and Fardel O (2005) Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab Dispos 33:1418-1422. (Pubitemid 41323987)
16. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, and Fardel O (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756-1763. (Pubitemid 44427479)
17. Kakizaki S, Yamazaki Y, Kosone T, Horiguchi N, Horigichi N, Sohara N, Sato K, Takagi H, Yoshinari K, and Mori M (2007) Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor. Liver Int 27:109-119. (Pubitemid 46139435)
18. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, and Edwards PA (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908-2915. (Pubitemid 34953324)
19. Keppler D (1999) Export pumps for glutathione S-conjugates. Free Radic Biol Med 27:985-991.
20. Koike C, Moore R, and Negishi M (2007) Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes. Mol Pharmacol 71:1217-1221. (Pubitemid 46658675)
21. Kullak-Ublick GA, Glasa J, Böker C, Oswald M, Grützner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, et al. (1997) Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113:1295-1305. (Pubitemid 27418984)
22. Le Vee M, Gripon P, Stieger B, and Fardel O (2008) Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 36:217-222. (Pubitemid 351185762)
23. Le Vee M, Lecureur V, Stieger B, and Fardel O (2009) Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-α or interleukin-6. Drug Metab Dispos 37:685-693.
24. Lindroos PM, Zarnegar R, and Michalopoulos GK (1991) Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 13:743-750.
25. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, and Williams R (1988) Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2:72-74. (Pubitemid 18163862)
26. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443. (Pubitemid 19277521)
27. Osabe M, Sugatani J, Takemura A, Yamazaki Y, Ikari A, Kitamura N, Negishi M, and Miwa M (2008) Expression of CAR in SW480 and HepG2 cells during G1 is associated with cell proliferation. Biochem Biophys Res Commun 369:1027-1033.
28. Richert L, Tuschl G, Abadie C, Blanchard N, Pekthong D, Mantion G, Weber JC, and Mueller SO (2009) Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol 235:86-96.
29. Roberts E, Ahluwalia MB, Lee G, Chan C, Sarma DS, and Farber E (1983) Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Cancer Res 43:28-34. (Pubitemid 13172790)
30. Rubin JS, Bottaro DP, and Aaronson SA (1993) Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1155:357-371. (Pubitemid 24012300)
31. Sekiyama KD, Yoshiba M, and Thomson AW (1994) Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98:71-77. (Pubitemid 24315454)
32. Song KH, Ellis E, Strom S, and Chiang JY (2007) Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology 46:1993-2002.
33. Tacchini L, De Ponti C, Matteucci E, Follis R, and Desiderio MA (2004) Hepatocyte growth factor-activated NF-κB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 25:2089-2100. (Pubitemid 39534845)
34. Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, and Gottesman MM (1987) Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236:1120-1122. (Pubitemid 17113259)
35. Trauner M and Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633-671. (Pubitemid 36378680)
36. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, and Kawakami S (1991) Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13:1-5.
37. Vos TA, Ros JE, Havinga R, Moshage H, Kuipers F, Jansen PL, and Müller M (1999) Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 29:1833-1839. (Pubitemid 29247058)
38. Xiong H, Yoshinari K, Brouwer KL, and Negishi M (2002) Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab Dispos 30:918-923. (Pubitemid 34815422)
39. Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, and Trauner M (2003) Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38:717-727. (Pubitemid 36613336)